Product Images Vizimpro

This is a chart that shows the Probability of Progression-Free Survival for two drugs, VIZIMPRO and Geftino. The numbers represent the number of patients in each group and their progression-free survival in months. The lower values on the chart indicate the number of patients at each interval. There are some censored patients in the VIZIMPRO group.*

This appears to be a chart showing Overall Survival for two different treatments: vizmpRO and Gefitinib. It shows the number of patients at risk and the months survived for each treatment. The data is censored, meaning not all outcomes are known.*

This text is a statement indicating the distributing company for a product. The name of the company is Pfizer Labs, which is a division of Pfizer Inc, located in NY with zip code 10017.*

This text is a brief description of a division of Pfizer Inc, called Pfizer Labs, and its distribution activities.*

This text provides storage instructions and dosage information for Vizimpro, a tablet medication containing 15 mg of dacomitinib. It instructs to store the medication between 20°C to 25°C and dispense in tight, child-resistant containers. The medication is distributed by U.S. Pharmaceuticals Piizer Inc and is made in Ireland. The text also includes a professional sample disclaimer and reference to the accompanying prescribing information. The product is not for sale and the given NDC and code are for identification purposes only.*